MxA expression in PBMC, also used as a surrogate for the IFN signature, had a very strong correlation with muscle disease activity of JDM patients (rs = 0.80) at disease onset, but not with skin disease activity (89). The gene discussed is IFNA1; the disease is juvenile dermatomyositis.